Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Immunicum financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
KR10.4
2024-10-29
Market Capitalization
KR525 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| SEK | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 16.7M | |||||||
| Gross profit | 184.0K | 16.7M | 9.0K | 3.4M | 28.5M | 4.6M | 7.8M | |
| Gross profit margin, % | 100.0% | |||||||
| Operating expense total | 98.0M | 60.7M | 85.1M | 129.1M | 132.2M | 123.4M | 125.7M | 116.6M |
| Depreciation and amortization | 60.0K | 832.0K | 887.0K | 993.0K | 4.8M | 6.3M | 9.5M | 4.8M |
| EBITDA | (97.8M) | (44.0M) | (85.1M) | (129.1M) | (128.8M) | (94.9M) | (121.1M) | (108.8M) |
| EBITDA margin, % | -263.8% | |||||||
| EBIT | (97.8M) | (44.9M) | (86.0M) | (130.1M) | (133.7M) | (101.2M) | (130.5M) | (113.6M) |
| EBIT margin, % | -268.8% | |||||||
| Interest income | 163.0K | 2.1M | 3.5M | 3.5M | ||||
| Interest expense | 14.0K | 2.9M | 3.2M | 3.3M | 5.3M | 3.1M | 1.2M | 3.3M |
| Pre tax profit | (97.9M) | (47.8M) | (89.2M) | (133.4M) | (138.8M) | (101.6M) | (128.4M) | (113.3M) |
| Net Income | (97.9M) | (47.8M) | (89.2M) | (133.4M) | (138.8M) | (101.6M) | (128.4M) | (113.3M) |